my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Oxford BioMedica is a biopharmaceutical company specializing in cancer immunotherapy and gene-based therapies. The Company was established in 1995, as a spin-out from Oxford University, and is listed on the London Stock Exchange. The Company has a platform of gene delivery technologies, which are ba more
Oxford BioMedica plc announced that it has signed an agreement with Novartis to manufacture clinical grade material utilising Oxford BioMedica’s LentiVector® gene delivery technology. Under the terms of the agreement, Oxford BioMedica will also provide certain process development services and expec more
Oxford BioMedica announced the appointment of Martin Diggle as a non-Executive Director of the Company, effective as of 4 October 2012.Martin is a founder of Vulpes Investment Management, a Cayman Fund Manager which currently manages five funds including the Vulpes Life Sciences Fund; Oxford BioMedi more
Oxford BioMedica plc announced that its partners at Cardiff University, Wales (UK) have initiated a Phase II trial to assess the safety and immunological activity of TroVax®, a therapeutic vaccine developed by Oxford BioMedica, in patients with inoperable metastatic colorectal cancer (CRC). The stu more
Dechra Pharmaceuticals PLC (Dechra) is engaged in the manufacture and distribution of veterinary medicines. It also sells various veterinary products through partnership with other companies. Additionally, the company offers laboratory services such as histology, pathology, haematology, chemistry an more
Language: en / da Sitemap Downloads Contact Search: Core Competences Pipeline Business Development Investor Join Us About Us Cancer Biodefence Infectious Diseases About Bavarian Nordic Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the trea more
Corporate Overview Mission Collaborations Management Team Board of Directors Scientific Advisors Contact Us Ethics Policy Management Team Alan W. Dunton, M.D. President and Chief Executive Officer Alan W. Dunton, M.D. has served as our Chief Executive Officer since January 2007 an more
About Lipoxen Home About Lipoxen Business Strategy Directors Sir Brian Richards, CBE, BSc, PhD, DSc M Scott Maguire Professor Gregory Gregoriadis PhD, DSc Dr Dmitry D Genkin Mr Colin William Hill, ACMA Mr Firdaus Jal Dastoor, FCS Mr Igor Nikolaev Senior Management Our Technologies Pipeline Partnerin more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
